Barclays raised the firm’s price target on Johnson & Johnson to $166 from $159 and keeps an Equal Weight rating on the shares. The company ...

One such company is Intuitive Surgical ( ISRG -4.04%). The medical device specialist's market cap currently tops $215 billion ...

Barclays (LON:BARC) analyst Matt Miksic increased the price target for Johnson & Johnson (NYSE:JNJ) shares, taking it up to ...

HistoSonics, a medical device company backed by Johnson & Johnson’s venture capital arm, is exploring the possibility of a U.S. initial ...

The pharmaceutical company’s latest earnings exceeded Wall Street’s expectations as it braces for one of its top-selling ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/100.sbqKNnJW.js ...

Julie Whytock said she spent 26 weeks in hospital after her cancer diagnosis (Photo: supplied (left) Justin Sullivan/Getty ...

Johnson & Johnson surpassed earnings expectations with strong sales, but it faces challenges ahead due to patent expirations.

This fall, pharmaceutical and medical technology company Johnson & Johnson announced that a newly created Dallas subsidiary ...

The institutional investor owned 43,167 shares of the company’s stock after purchasing an additional 2,058 shares during the period. Johnson & Johnson makes up approximately 1.6% of Ellsworth ...

Johnson & Johnson has a 12 month low of $140.68 and a 12 month high of $168.85. The company has a fifty day moving average price of $148.35 and a two-hundred day moving average price of $156.11.

TORONTO, Jan. 23, 2025 /CNW/ - Johnson & Johnson (NYSE: JNJ) is proud to announce a Canadian first: the publication of a consensus statement titled, "Optimizing the management of psoriasis in patients ...